JNJ’s Consistent Payout Makes It a Top Pick for Down Markets
The company is facing a combination of slow revenue growth, unresolved legal battles over talc products, and looming drug price negotiations under new Medicare rules.
Posts Tagged ‘Johnson & Johnson (NYSE:JNJ)’
10 Undervalued Blue Chip Stocks Analysts Recommend for Smart Investing
Blue-chip stocks are great assets for investors looking for opportunities to grow their capital in the long term. Some call them steady oaks in the forest of finance.
10 Best Dividend Stocks for a Bear Market
According to Ned Davis Research, the broader market is now less than 3% below its all-time high from February, and only a recession would likely cause a significant pullback.
Johnson & Johnson (JNJ) Announces Results for Phase 3b APEX Study
Johnson & Johnson (NYSE:JNJ) is one of the 10 Cheapest High-Quality Stocks to Buy According to Hedge Funds.
UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times
On June 12, UBS global equity strategist Andrew Garthwaite’s team pointed to Johnson & Johnson as one of the top cyclical picks, excluding financials, whose performance tends...
Retirement Stock Portfolio: 10 Safe Dividend Stocks to Buy Now
Dividend-paying stocks are often considered a dependable option for retirement portfolios.
10 Cheapest High Quality Stocks to Buy According to Hedge Funds
On June 4, Jurrien Timmer, director of Global Macro for Fidelity Management & Research Company released his commentary on the stock market outlook.
Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit
Recently, a federal judge ruled that a Johnson & Johnson subsidiary must pay $442 million in damages after a jury concluded last month that the company had broken antitrust laws...
Dow 20 Stocks List: Ranked By Hedge Fund Bullishness Index
The Dow Jones Industrial Average, often called the Dow Jones or just the Dow, is a stock market index that tracks 30 major publicly traded companies in the United States.
US FDA Votes in Favor of Benefit-Risk Profile of Johnson & Johnson’s DARZALEX FASPRO
On May 20, Johnson & Johnson (NYSE:JNJ) announced that the FDA Oncologic Drugs Advisory Committee/ODAC voted 6-2 in favor of the benefit-risk profile of single-agent DARZALEX ...
Jim Cramer Notes That “People Are Staying Away From” Johnson & Johnson
“Or let's consider Johnson & Johnson, triple A balance sheet, many drugs in the pipeline, one of the best-run companies in America, if not the world, with perhaps the most billion...
Jim Cramer Commented on 7 Hard-to-Own Safety Stocks
“When interest rates go up, even if they go up just a little, you can see lots of very good well-known stocks with juicy dividends just get pummeled.
13 Best Cheap Stocks to Invest in for Beginners
The last time the S&P erased a 15% decline in under six weeks was 1982, which tells a lot about the current market dynamics we are currently in.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
10 Best Income Stocks to Invest in Now
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
11 Best Medical Device Stocks to Buy Now
On April 16, CNBC reported that Trump's tariffs are building a divide in the medical community.
ChatGPT Stock Advice: Top 12 Stock Recommendations
This article looks at ChatGPT Stock Advice: Top 12 Stock Recommendations.
Did Jim Cramer Hit or Miss On These 13 Stock Predictions?
“Alright, look, lately, we can’t go a day without hearing some widespread misperceptions about stock ownership. I gotta tell you, I think it’s infuriating.
10 Most Profitable Cheap Stocks to Buy Now
US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted impressive gains.
Jim Cramer Reveals Details Of Trump’s Tariff Negotiations & Discusses 10 Stocks
In his recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the supply chain disruption that firms were facing and planning for in the wake of President Trump...
The Best and Worst Dow Stocks for the Next 12 Months
The Dow Jones Industrial Average (DJIA), or the Dow, is a price-weighted index that has long been seen as a barometer of the health of the U.S. economy.
10 Best Long-Term Dividend Stocks to Buy According to Billionaires
Dividend stocks are increasingly popular with both every day and billionaire investors.
Top 10 Stocks to Watch as Investors Brace for Recession
Despite some optimism in the market after President Donald Trump’s indication of possible talks with China, Wall Street analysts are warning about recession risks due to the...
10 Stocks Analysts are Talking About Amid Trump’s Tariff War
Markets saw some glimmer of hope as President Donald Trump indicated that he does not plan to fire Federal Reserve Chair Jerome Powell and showed openness to engage in talks with...
10 Most Profitable Blue Chip Stocks to Buy Now
Blue chip stocks are large, financially stable companies with strong market presence, consistent profitability, and regular dividend payments.
11 Best Safe Stocks to Buy According to Hedge Funds
In times when you never know what you’ll wake up to the next morning, playing safe seems to be the wisest choice.
Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed whether President Trump could fire the chairman of the Federal Reserve, Jerome Powell.
13 Best American Dividend Stocks to Buy According to Analysts
Dividend-paying stocks have long benefited investors by delivering consistent and solid returns.
10 Best Low Volatility Stocks to Buy Now
The US stock market experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices.
10 Value Stocks in Ken Fisher’s Portfolio
Trump's "stupid" tariffs will fail; that's the sentiment echoed by billionaire investor Ken Fisher as their impact continues to be felt far and wide.
Jim Cramer Sees Opportunity in Pessimism and Highlights These 12 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer pushed back against widespread pessimism surrounding the U.S.
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
10 Best Dividend Monarchs to Invest in Now
Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware of a lesser-known group called Dividend...
Jim Cramer Sounds the Alarm on China Rhetoric and Dollar Panic Then Analyzes 11 Key Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer reacted to the partial tariff exemptions announced by the White House, interpreting them not as a full retreat...
Jim Cramer’s Game Plan: 15 Stocks to Watch
He noted the chaotic nature of the current environment and remarked that "this tape has it all," and emphasized how unpredictable developments from the White House have added ...
11 Best Dividend Paying Stocks to Buy According to Hedge Funds
Dividend-paying stocks have consistently attracted investor interest due to their long-term value.
Jim Cramer Questions Market Logic and Dissects These 7 Key Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer unpacked the deepening uncertainty gripping both markets and politics as investors brace for higher inflation...
11 Cheap NYSE Stocks to Invest in According to Hedge Funds
On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends in a discussion on CNBC's 'Squawk Box'.
10 Best Medical Stocks to Buy According to Billionaires
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
Jim Cramer Says Tariff Pain Isn’t Over Yet And Reviews These 9 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer dissected the market’s recent rally and reminded his viewers to not mistake short-term optimism for resolution...
10 Defensive Stocks Billionaire Ken Fisher Is Betting On
Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher Asset Management.
Jim Cramer’s Hidden Market Sectors Amidst Tariffs & 8 Stocks
On his appearance on CNBC's Squawk on the Street on Thursday, Jim Cramer commented on the global response to President Trump's tariffs.
10 Best Healthcare Stocks to Buy According to Billionaires
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
15 Best Dividend Aristocrat Stocks with Over 3% Yield
Dividend Aristocrats are the companies that have raised their payouts for 25 consecutive years or more.
Jim Cramer Says Trump’s Tariff Strategy Is Working & Discusses These 11 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the outcomes of President Trump's tariffs and whether Trump is hostile to the markets.
Jim Cramer Focused On These 9 Stocks Recently
Jim Cramer, host of Mad Money, expressed his frustration on March 19 about how investors often get caught up in discussions revolving around the Federal Reserve, interest rates...
13 Best Healthcare Dividend Stocks to Invest in
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
Did Jim Cramer Get These 23 Stocks Right?
In this article, we will take a look at 23 stocks that Jim Cramer discussed 12 months ago during his show on March 25, 2024, and examine whether he was right or wrong about those...
Jim Cramer’s Latest Stock Moves: Top 10 Calls
Jim Cramer in a recent program on CNBC expressed his frustration over the recent market selloff following tariff uncertainties.
Was Jim Cramer Right About These 16 Stocks?
In this article, we will take a look at 16 stocks that Jim Cramer discussed 12 months ago during his show on March 18, 2024, and examine whether he was right or wrong about those...
